At Able Therapeutics, our unique science is based on a simple but profound hypothesis: Bacteria spores are the culprit in many insidious health challenges, and we believe it is possible to target and control spore germination, making it impossible for those spores to cause disease. By stopping the spore cycle and their production of toxins, Able Therapeutics is pioneering an entirely new paradigm in infectious disease control in humans and animals.
Our belief is that it is better to prevent the spore activity and runaway infections in the first place rather than block enzymes as a treatment after the infection has already taken root.
